Real-time enrollment status for this solid tumors clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 10:32 AM UTC
| NCT Number | NCT04198766 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Solid Tumors |
| Phase | Clinical Trial |
| Target Enrollment | 333 participants |
| Active Locations | 30 sites in the US |
| Sponsor | Inhibrx Biosciences, Inc |
| Last Updated on CT.gov | December 18, 2025 (Dec 18, 2025) |
As of March 2, 2026: Clinical trial NCT04198766 is currently active_not_recruiting participants. This clinical trial study for solid tumors is not currently accepting new participants at 30 locations across the United States. The study is sponsored by Inhibrx Biosciences, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT04198766 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 30 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04198766 was last updated Dec 18, 2025 (December 18, 2025). HelloStudys verifies this status automatically.